Copyright
©2014 Baishideng Publishing Group Inc.
World J Meta-Anal. Nov 26, 2014; 2(4): 154-161
Published online Nov 26, 2014. doi: 10.13105/wjma.v2.i4.154
Published online Nov 26, 2014. doi: 10.13105/wjma.v2.i4.154
Study characteristic | Has results | No results available | Total | Percent with the results |
Subject age | ||||
Child | 21 | 78 | 99 | 21.21 |
Child/adult | 6 | 37 | 43 | 13.95 |
Child/adult/senior | 28 | 117 | 145 | 19.31 |
Adult | 17 | 192 | 209 | 8.13 |
Adult/senior | 260 | 1301 | 1561 | 16.66 |
Senior | 3 | 2 | 5 | 60.00 |
Subject sex | ||||
Both | 293 | 1536 | 1829 | 16.02 |
Female | 22 | 131 | 153 | 14.38 |
Male | 20 | 60 | 80 | 25.00 |
Total | 335 | 1727 | 2062 | 16.25 |
Sponsorship | ||||
Industry | 322 | 1566 | 1888 | 17.06 |
Industry combined with non-industry sources | 12 | 63 | 75 | 16.00 |
Non industry sponsors | 1 | 98 | 99 | 1.01 |
Examined Interventions | ||||
Behavioral | 0 | 9 | 9 | 0.00 |
Biological | 14 | 115 | 129 | 10.85 |
Device | 0 | 17 | 17 | 0.00 |
Dietary supplement | 1 | 3 | 4 | 25 |
Drug | 315 | 1468 | 1783 | 17.67 |
Genetic | 0 | 1 | 1 | 0.00 |
Other | 0 | 22 | 22 | 0.00 |
Procedure | 0 | 31 | 31 | 0.00 |
Radiation | 0 | 1 | 1 | 0.00 |
Phases of clinical trials | ||||
Phase 1 | 1 | 42 | 43 | 2.33 |
Phase 1/phase 2 | 3 | 31 | 34 | 8.82 |
Phase 2 | 58 | 429 | 487 | 11.91 |
Phase 2/phase 3 | 8 | 43 | 51 | 15.69 |
Phase 3 | 221 | 936 | 1157 | 19.10 |
Phase 4 | 38 | 133 | 171 | 22.22 |
Recruitment | ||||
Active, not recruiting | 25 | 339 | 364 | 6.87 |
Approved for marketing | 0 | 2 | 2 | 0.00 |
Available | 0 | 3 | 3 | 0.00 |
Completed | 288 | 744 | 1032 | 27.91 |
Enrolling by invitation | 0 | 20 | 20 | 0.00 |
No longer available | 0 | 1 | 1 | 0.00 |
Not yet recruiting | 0 | 25 | 25 | 0.00 |
Recruiting | 0 | 481 | 481 | 0.00 |
Suspended | 0 | 3 | 3 | 0.00 |
Temporarily not available | 0 | 1 | 1 | 0.00 |
Terminated | 22 | 100 | 122 | 18.03 |
Interventional | 327 | 1624 | 1951 | 16.76 |
Observational | 8 | 96 | 104 | 7.69 |
Study characteristics | Published | Unpublished | Total | Percent published |
Age | ||||
Adult | 26 | 183 | 209 | 12.4 |
Adult/senior | 327 | 1234 | 1561 | 20.9 |
Child | 7 | 92 | 99 | 7.1 |
Child/adult | 3 | 40 | 43 | 7.0 |
Child/adult/senior | 18 | 127 | 145 | 12.4 |
Senior | 2 | 3 | 5 | 40.0 |
Sex | ||||
Both | 352 | 1477 | 1829 | 19.2 |
Female | 23 | 130 | 153 | 15.0 |
Male | 8 | 72 | 80 | 10.0 |
Sponsorship | ||||
Industry | 354 | 1534 | 1888 | 18.8 |
Industry/National Institutes of Health | 0 | 2 | 2 | 0.0 |
Industry/other | 14 | 42 | 56 | 25.0 |
Industry/other/ National Institutes of Health | 0 | 1 | 1 | 0.0 |
Industry/United States Fed | 1 | 1 | 2 | 50.0 |
Other/industry | 0 | 13 | 13 | 0.0 |
Other/National Institutes of Health/industry | 0 | 1 | 1 | 0.0 |
National Institutes of Health | 4 | 6 | 10 | 40.0 |
National Institutes of Health/other | 0 | 1 | 1 | 0.0 |
Other | 10 | 70 | 80 | 12.5 |
Other/National Institutes of Health | 0 | 8 | 8 | 0.0 |
Interventions | ||||
Behavioral | 2 | 7 | 9 | 22.2 |
Biological | 10 | 119 | 129 | 7.8 |
Device | 1 | 16 | 17 | 5.9 |
Dietary supplement | 1 | 3 | 4 | 25.0 |
Drug | 359 | 1424 | 1783 | 20.1 |
Genetic | 0 | 1 | 1 | 0.0 |
Other | 2 | 20 | 22 | 9.1 |
Procedure | 5 | 26 | 31 | 16.1 |
Radiation | 0 | 1 | 1 | 0.0 |
Phases of clinical trials | ||||
Phase 1 | 0 | 43 | 43 | 0.0 |
Phase 1/phase 2 | 3 | 31 | 34 | 8.8 |
Phase 2 | 68 | 419 | 487 | 14.0 |
Phase 2/phase 3 | 5 | 46 | 51 | 9.8 |
Phase 3 | 257 | 900 | 1157 | 22.2 |
Phase 4 | 40 | 131 | 171 | 23.4 |
Recruitment | ||||
Active, not recruiting | 51 | 313 | 364 | 14.0 |
Approved for marketing | 1 | 1 | 2 | 50.0 |
Completed | 285 | 747 | 1032 | 27.6 |
No longer available | 1 | 0 | 1 | 100 |
Suspended | 0 | 3 | 3 | 0.0 |
Temporarily not available | 0 | 1 | 1 | 0.0 |
Terminated | 23 | 99 | 122 | 18.9 |
Withdrawn | 0 | 8 | 8 | 0.0 |
Study type | ||||
Interventional | 375 | 1576 | 1951 | 19.2 |
Observational | 6 | 98 | 104 | 5.8 |
Posting the results in clinicaltrials.gov | ||||
Has results | 143 | 192 | 335 | 42.7 |
No results available | 240 | 1487 | 1727 | 13.9 |
Study characteristic | Sum | Mean | Std Dev | Median |
Subject age | ||||
Adult | 122622 | 592 | 1334 | 353 |
Adult/senior | 1817056 | 1181 | 2836 | 462 |
Child | 35069 | 358 | 891 | 172 |
Child/adult | 9727 | 226 | 335 | 100 |
Child/adult/senior | 415280 | 2925 | 9863 | 450 |
Senior | 9816 | 1963 | 2158 | 450 |
Subject sex | ||||
Both | 2224171 | 1232 | 3849 | 423 |
Female | 132363 | 877 | 1388 | 419 |
Male | 53036 | 689 | 1143 | 300 |
Sponsorship | ||||
Industry | 2130061 | 1142 | 3628 | 432 |
Industry/National Institutes of Health | 465 | 465 | 465 | |
Industry/other | 123747 | 2250 | 4293 | 500 |
Industry/other/National Institutes of Health | 8381 | 8381 | 8381 | |
Industry/United States Fed | 750 | 375 | 318 | 375 |
National Institutes of Health | 30401 | 3040 | 5516 | 860 |
National Institutes of Health/other | 280 | 280 | 280 | |
Other | 91308 | 1201 | 3831 | 145 |
Other/industry | 17011 | 1309 | 2776 | 200 |
Other/National Institutes of Health | 4166 | 521 | 477 | 335 |
Other/National Institutes of Health/ industry | 3000 | 3000 | 3000 | |
Interventions | ||||
Behavioral | 23514 | 2613 | 5846 | 400 |
Biological | 116476 | 917 | 3958 | 288 |
Device | 16116 | 948 | 2458 | 90 |
Dietary supplement | 1712 | 428 | 605 | 150 |
Drug | 2058994 | 1171 | 3623 | 448 |
Genetic | 100 | 100 | 100 | |
Other | 27135 | 1292 | 3539 | 160 |
Procedure | 8566 | 276 | 381 | 150 |
Phases of clinical trials | ||||
Phases = phase 1 | 2412 | 56 | 63 | 36 |
Phases = phase 1/phase 2 | 3690 | 109 | 104 | 98 |
Phases = phase 2 | 149238 | 310 | 374 | 200 |
Phases = phase 2/phase 3 | 31469 | 629 | 960 | 295 |
Phases = phase 3 | 1443064 | 1267 | 2773 | 587 |
Phases = phase 4 | 234401 | 1379 | 3495 | 391 |
Recruitment | ||||
Completed | 1355817 | 1331 | 4549 | 460 |
Suspended | 792 | 264 | 216 | 210 |
Terminated | 110736 | 915 | 2501 | 284 |
Withdrawn | 540 | 77 | 133 | 0 |
Study type | ||||
Interventional | 1845794 | 956 | 2415 | 404 |
Observational | 563776 | 5421 | 11639 | 1069 |
Posting of the results in clinicaltrials.gov | ||||
Study results = has results | 524214 | 1570 | 4804 | 484 |
Study results = no results available | 1885356 | 1109 | 3381 | 402 |
Terminated studies with no results available | 102335 | 1034 | 2740 | |
Terminated studies with posted results | 8401 | 382 | 573 | |
Terminated unpublished studies with posted results | 3554 | 209 | 217 | |
Terminated unpublished studies without posted results | 38111 | 471 | 760 | |
Publication | ||||
Published | 902735 | 2401 | 5662 | 670 |
Unpublished | 1506835 | 909 | 2954 | 383 |
- Citation: Shamliyan TA, Avanesova AA. Russian clinical research policy does not guarantee results availability. World J Meta-Anal 2014; 2(4): 154-161
- URL: https://www.wjgnet.com/2308-3840/full/v2/i4/154.htm
- DOI: https://dx.doi.org/10.13105/wjma.v2.i4.154